RTA Laboratuvarlari Biyolojik Cash Flow Quality Index
RTA Laboratuvarlari Biyolojik cash flow quality index. RTA Laboratuvarlari Biyolojik (RTALB) has a Cash Flow Quality Index of 0.23x as of June 2025. Operating cash flow of TL20.98 Million is below net income of TL91.75 Million, suggesting accrual-heavy earnings not yet converted to cash. See RTALB financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of RTA Laboratuvarlari Biyolojik (2014–2024)
Cash flow quality index of RTA Laboratuvarlari Biyolojik from 2014 to 2024. Historical Cash Flow Quality Index for RTA Laboratuvarlari Biyolojik across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore RTA Laboratuvarlari Biyolojik cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
RTA Laboratuvarlari Biyolojik Cash Flow Quality Index by Year (2014–2024)
RTA Laboratuvarlari Biyolojik cash flow quality index by year from 2014 to 2024. Year-by-year earnings quality comparison for RTA Laboratuvarlari Biyolojik. For the full cash flow conversion analysis, see RTALB cash flow metrics.
| Year | Quality Index | Operating CF (TRY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.62x | TL-84.45 Million | TL52.23 Million | ▼ -222.7% |
| 2022 | -0.50x | TL-140.82 Million | TL281.12 Million | ▼ -183.4% |
| 2021 | 0.60x | TL68.78 Million | TL114.47 Million | ▲ +290.7% |
| 2020 | 0.15x | TL9.37 Million | TL60.93 Million | ▼ -81.0% |
| 2019 | 0.81x | TL3.58 Million | TL4.42 Million | ▲ +130.6% |
| 2018 | -2.64x | TL-5.81 Million | TL2.20 Million | ▼ -881.0% |
| 2017 | 0.34x | TL1.41 Million | TL4.16 Million | ▼ -51.7% |
| 2016 | 0.70x | TL2.86 Million | TL4.09 Million | ▼ -15.4% |
| 2015 | 0.83x | TL6.18 Million | TL7.48 Million | ▲ +45.3% |
| 2014 | 0.57x | TL2.58 Million | TL4.54 Million | — |